Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PTSC is still viewed by a relatively narrow audience

PTSC is still viewed by a relatively narrow audience

posted on Oct 06, 2006 08:38AM
When the numbers become crunchable, with verification and projections for year over year, expectations should grow. Looking forward to see what direction management will take this via acquisition, dividend play and nasdaq listing...all pheromones for investors.
Share
New Message
Please login to post a reply